New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
IDEAYA Biosciences, Inc.
IDYA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2B

Biotechnology

Next Earning date - 05 Nov 2024

2B

Biotechnology

Next Earning date - 05 Nov 2024

29.20USD
Shape-0.30 ( -1.02%)
favorite-chart

Relative Strenght

77
favorite-chart

Volume Buzz

-20%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

39%

Quote Panel

Shape
Updated October 25, 2024
1W -5.44 % 1M -4.26 % 3M -31.12 % 1Y 7.91 %

Key Metrics

Shape
  • Market Cap

    2.47B


  • Shares Outstanding

    84.48M


  • Share in Float

    76.56M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    29.2


  • Average Volume

    697526


  • Beta

    0.816


  • Range

    25.22-47.735


  • Industry

    Biotechnology


  • Website

    https://www.ideayabio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

206.24x

P/S Ratio

2.44x

P/B Ratio

0.0

Debt/Equity

-1285.3%

Net Margin

$-2.2

EPS

How IDYA compares to sector?

P/E Ratio

Relative Strength

Shape

IDYA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$15M

ShapeNaN%

2025-Revenue

$2.87

Shape-321%

2025-EPS

$9M

Shape86%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

UBS

initialise

Previous: Not converted

2024-10-24

Now: Buy

Cantor Fitzgerald

initialise

Previous: Not converted

2024-10-15

Now: Overweight

Janney Montgomery

initialise

Previous: Not converted

2022-12-28

Now: Buy

Morgan Stanley

initialise

Previous: Not converted

2022-12-28

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+113%

0.04
vs -0.31

Q4.22

arrow
arrow

N/A

-0.50
vs -0.47

Q1.23

arrow
arrow

N/A

-0.49
vs -0.36

Q2.23

arrow
arrow

N/A

-0.50
vs -0.57

Q3.23

arrow
arrow

N/A

-0.46
vs 0.04

Q4.23

arrow
arrow

N/A

-0.52
vs -0.50

Q1.24

arrow
arrow

N/A

-0.53
vs -0.49

Q2.24

arrow
arrow

N/A

-0.68
vs -0.50

Q3.24

arrow
arrow

N/A

-0.65
vs -0.46

Q4.24

arrow
arrow

N/A

-0.64
vs -0.52

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+231%

29.7M  vs 9M

Q4.22

arrow
arrow

+36%

4M  vs 3M

Q1.23

arrow
arrow

-31%

7.9M  vs 11.4M

Q2.23

arrow
arrow

-39%

3.5M  vs 5.9M

Q3.23

arrow
arrow

-73%

8M  vs 29.7M

Q4.23

arrow
arrow

-2%

3.9M  vs 4M

Q1.24

arrow
arrow

-100%

NA  vs 7.9M

Q2.24

arrow
arrow

-100%

NA  vs 3.5M

Q3.24

arrow
arrow

-46%

4.3M  vs 8M

Q4.24

arrow
arrow

+47%

5.8M  vs 3.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+1%

0.01
vs -0.08

Q4.22

arrow
arrow

-6%

-0.06
vs 0.01

Q1.23

arrow
arrow

-6%

-0.06
vs -0.06

Q2.23

arrow
arrow

-6%

-0.06
vs -0.06

Q3.23

arrow
arrow

-5%

-0.05
vs -0.06

Q4.23

arrow
arrow

-5%

-0.05
vs -0.05

Q1.24

arrow
arrow

-4%

-0.04
vs -0.05

Q2.24

arrow
arrow

-6%

-0.06
vs -0.04

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

114

114
vs 98

16%

Q4.22

arrow
arrow

121

121
vs 114

6%

Q1.23

arrow
arrow

127

127
vs 121

5%

Q2.23

arrow
arrow

143

143
vs 127

13%

Q3.23

arrow
arrow

146

146
vs 143

2%

Q4.23

arrow
arrow

159

159
vs 146

9%

Q1.24

arrow
arrow

206

206
vs 159

30%

Q2.24

arrow
arrow

201

201
vs 206

-2%

Earnings Growth

Latest News